Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus

Physical and chemical factors, obesity, lipid metabolism disorder, diabetes affect the state of the vascular endothelium, the processes of thrombus formation, fibrinolysis and increase the risk of developing cardiovascular diseases. It can be assumed that the development and course of pathological p...

Full description

Bibliographic Details
Main Authors: L. B. Masnavieva, I. V. Kudaeva, Yu. A. Kuznetsova
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2020-04-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/1739
_version_ 1797197885444456448
author L. B. Masnavieva
I. V. Kudaeva
Yu. A. Kuznetsova
author_facet L. B. Masnavieva
I. V. Kudaeva
Yu. A. Kuznetsova
author_sort L. B. Masnavieva
collection DOAJ
description Physical and chemical factors, obesity, lipid metabolism disorder, diabetes affect the state of the vascular endothelium, the processes of thrombus formation, fibrinolysis and increase the risk of developing cardiovascular diseases. It can be assumed that the development and course of pathological processes in the cardiovascular system, caused by vibration disease with the onset of diabetes, will undergo changes. The purpose of the study was to assess the state of heart condition according to the level of specific autoantibodies with the combined effect of vibration disease and type 2 diabetes mellitus. Patients with vibration disease (group I), patients with type 2 diabetes (group II) and persons with vibration disease in combination with type 2 diabetes (group III) were examined. Individuals do not have a history of coronary heart disease, stroke, and myocardial infarction have been included in obsledrovanie. Serum levels of specific autoantibodies characterizing the state of the heart have been studied. It was revealed that the content of autoantibodies to 1-adrenoreceptors in patients of group I was higher than in individuals of group II. The relative content of autoantibodies to the components of the membrane and cytoplasm of myocardial cells in patients of groups I-III did not differ. It was found that elevated levels of autoantibodies to components of the membrane and cytoplasm of myocardial cells, cardiomyosin, 1-adrenoreceptors were observed more often in patients with vibration disease combined with diabetes and in persons with vibration disease than in people with diabetes. Persons with a reduced content of autoantibodies to 1-adrenergic receptors were not detected among patients of groups I and III. Changes in the levels of specific autoantibodies in persons with vibration disease may indicate the development of functional metabolic and structural changes in the heart, disorders of its electrical activity that have not yet been manifested in the form of a pathological process. Lower levels of 1-adrenoceptor autoantibodies in patients with type 2 diabetes without vibration disease can be caused by increased levels of catecholamines, which is characteristic of diabetics. Further research, including clinical data and indicators of functional diagnostics is necessary to confirm our assumptions.
first_indexed 2024-03-08T05:47:38Z
format Article
id doaj.art-64971de9301f4dc9a13d45de2797d203
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2024-04-24T06:51:04Z
publishDate 2020-04-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-64971de9301f4dc9a13d45de2797d2032024-04-22T13:07:45ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2020-04-0122231131810.15789/1563-0625-AAM-17391263Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitusL. B. Masnavieva0I. V. Kudaeva1Yu. A. Kuznetsova2East-Siberian Institute of Medical and Ecological ResearchEast-Siberian Institute of Medical and Ecological ResearchEast-Siberian Institute of Medical and Ecological ResearchPhysical and chemical factors, obesity, lipid metabolism disorder, diabetes affect the state of the vascular endothelium, the processes of thrombus formation, fibrinolysis and increase the risk of developing cardiovascular diseases. It can be assumed that the development and course of pathological processes in the cardiovascular system, caused by vibration disease with the onset of diabetes, will undergo changes. The purpose of the study was to assess the state of heart condition according to the level of specific autoantibodies with the combined effect of vibration disease and type 2 diabetes mellitus. Patients with vibration disease (group I), patients with type 2 diabetes (group II) and persons with vibration disease in combination with type 2 diabetes (group III) were examined. Individuals do not have a history of coronary heart disease, stroke, and myocardial infarction have been included in obsledrovanie. Serum levels of specific autoantibodies characterizing the state of the heart have been studied. It was revealed that the content of autoantibodies to 1-adrenoreceptors in patients of group I was higher than in individuals of group II. The relative content of autoantibodies to the components of the membrane and cytoplasm of myocardial cells in patients of groups I-III did not differ. It was found that elevated levels of autoantibodies to components of the membrane and cytoplasm of myocardial cells, cardiomyosin, 1-adrenoreceptors were observed more often in patients with vibration disease combined with diabetes and in persons with vibration disease than in people with diabetes. Persons with a reduced content of autoantibodies to 1-adrenergic receptors were not detected among patients of groups I and III. Changes in the levels of specific autoantibodies in persons with vibration disease may indicate the development of functional metabolic and structural changes in the heart, disorders of its electrical activity that have not yet been manifested in the form of a pathological process. Lower levels of 1-adrenoceptor autoantibodies in patients with type 2 diabetes without vibration disease can be caused by increased levels of catecholamines, which is characteristic of diabetics. Further research, including clinical data and indicators of functional diagnostics is necessary to confirm our assumptions.https://www.mimmun.ru/mimmun/article/view/1739autoantibodiesvibration diseasediabetescardiovascular systemheartp1-adrenergic receptor
spellingShingle L. B. Masnavieva
I. V. Kudaeva
Yu. A. Kuznetsova
Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus
Медицинская иммунология
autoantibodies
vibration disease
diabetes
cardiovascular system
heart
p1-adrenergic receptor
title Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus
title_full Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus
title_fullStr Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus
title_full_unstemmed Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus
title_short Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus
title_sort autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus
topic autoantibodies
vibration disease
diabetes
cardiovascular system
heart
p1-adrenergic receptor
url https://www.mimmun.ru/mimmun/article/view/1739
work_keys_str_mv AT lbmasnavieva autoantibodyasmarkersoftheheartstateinpatientswithvibrationdiseaseburdeneddiabetesmellitus
AT ivkudaeva autoantibodyasmarkersoftheheartstateinpatientswithvibrationdiseaseburdeneddiabetesmellitus
AT yuakuznetsova autoantibodyasmarkersoftheheartstateinpatientswithvibrationdiseaseburdeneddiabetesmellitus